Literature DB >> 4167915

Prophylaxis in rubella.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4167915      PMCID: PMC1748621     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  9 in total

1.  PREVENTION OF RUBELLA BY GAMMA GLOBULIN DURING AN EPIDEMIC IN BARROW, ALASKA, IN 1964.

Authors:  J A BRODY; J L SEVER; G M SCHIFF
Journal:  N Engl J Med       Date:  1965-01-21       Impact factor: 91.245

2.  Gamma-globulin for Prevention of Rubella in Pregnancy.

Authors:  J C McDonald
Journal:  Br Med J       Date:  1963-08-17

3.  Prophylaxis of German measles with immune serum globulin.

Authors:  R F KORNS
Journal:  J Infect Dis       Date:  1952 Mar-Apr       Impact factor: 5.226

4.  The efficacy of gamma globulin in the prevention of German measles.

Authors:  M BASS; H B DAVIDSON
Journal:  NY Med       Date:  1949-12-05

5.  Gammaglobulin in prevention of rubella and congenital defect: a study of 30,000 pregnancies.

Authors:  J C McDonald; C S Peckham
Journal:  Br Med J       Date:  1967-09-09

6.  Attenuated rubella virus. I. Development and laboratory characterization.

Authors:  P D Parkman; H M Meyer; R L Kirschstein; H E Hopps
Journal:  N Engl J Med       Date:  1966-09-15       Impact factor: 91.245

7.  Rubella syndrome after inapparent maternal illness.

Authors:  G B Avery; G G Monif; J L Sever; S L Leikin
Journal:  Am J Dis Child       Date:  1965-10

8.  Rubella-virus hemagglutination-inhibition test.

Authors:  G L Stewart; P D Parkman; H E Hopps; R D Douglas; J P Hamilton; H M Meyer
Journal:  N Engl J Med       Date:  1967-03-09       Impact factor: 91.245

9.  FREQUENCY OF RUBELLA ANTIBODY AMONG PREGNANT WOMEN AND OTHER HUMAN AND ANIMAL POPULATIONS. A REPORT FROM THE COLLABORATIVE STUDY OF CEREBRAL PALSY.

Authors:  J L SEVER; G M SCHIFF; R J HUEBNER
Journal:  Obstet Gynecol       Date:  1964-02       Impact factor: 7.661

  9 in total
  1 in total

Review 1.  Passive immunization for the public health control of communicable diseases: current status in four high-income countries and where to next.

Authors:  Megan K Young; Allan W Cripps
Journal:  Hum Vaccin Immunother       Date:  2013-06-19       Impact factor: 3.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.